skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Single Journals remover idioma: Japonês remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma

Advani, Ranjana ; Flinn, Ian ; Popplewell, Leslie ; Forero, Andres ; Bartlett, Nancy L ; Ghosh, Nilanjan ; Kline, Justin ; Roschewski, Mark ; LaCasce, Ann ; Collins, Graham P ; Tran, Thu ; Lynn, Judith ; Chen, James Y ; Volkmer, Jens-Peter ; Agoram, Balaji ; Huang, Jie ; Majeti, Ravindra ; Weissman, Irving L ; Takimoto, Chris H ; Chao, Mark P ; Smith, Sonali M

The New England journal of medicine, 2018-11, Vol.379 (18), p.1711-1721 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
2
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Shanafelt, Tait D ; Wang, Xin V ; Kay, Neil E ; Hanson, Curtis A ; O’Brien, Susan ; Barrientos, Jacqueline ; Jelinek, Diane F ; Braggio, Esteban ; Leis, Jose F ; Zhang, Cong C ; Coutre, Steven E ; Barr, Paul M ; Cashen, Amanda F ; Mato, Anthony R ; Singh, Avina K ; Mullane, Michael P ; Little, Richard F ; Erba, Harry ; Stone, Richard M ; Litzow, Mark ; Tallman, Martin

The New England journal of medicine, 2019-08, Vol.381 (5), p.432-443 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
3
Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

Seymour, John F ; Kipps, Thomas J ; Eichhorst, Barbara ; Hillmen, Peter ; D’Rozario, James ; Assouline, Sarit ; Owen, Carolyn ; Gerecitano, John ; Robak, Tadeusz ; De la Serna, Javier ; Jaeger, Ulrich ; Cartron, Guillaume ; Montillo, Marco ; Humerickhouse, Rod ; Punnoose, Elizabeth A ; Li, Yan ; Boyer, Michelle ; Humphrey, Kathryn ; Mobasher, Mehrdad ; Kater, Arnon P

The New England journal of medicine, 2018-03, Vol.378 (12), p.1107-1120 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
4
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

Fervenza, Fernando C ; Appel, Gerald B ; Barbour, Sean J ; Rovin, Brad H ; Lafayette, Richard A ; Aslam, Nabeel ; Jefferson, Jonathan A ; Gipson, Patrick E ; Rizk, Dana V ; Sedor, John R ; Simon, James F ; McCarthy, Ellen T ; Brenchley, Paul ; Sethi, Sanjeev ; Avila-Casado, Carmen ; Beanlands, Heather ; Lieske, John C ; Philibert, David ; Li, Tingting ; Thomas, Lesley F ; Green, Dolly F ; Juncos, Luis A ; Beara-Lasic, Lada ; Blumenthal, Samuel S ; Sussman, Amy N ; Erickson, Stephen B ; Hladunewich, Michelle ; Canetta, Pietro A ; Hebert, Lee A ; Leung, Nelson ; Radhakrishnan, Jay ; Reich, Heather N ; Parikh, Samir V ; Gipson, Debbie S ; Lee, Dominic K ; da Costa, Bruno R ; Jüni, Peter ; Cattran, Daniel C

The New England journal of medicine, 2019-07, Vol.381 (1), p.36-46 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
5
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Obinutuzumab for the First-Line Treatment of Follicular Lymphoma

Marcus, Robert ; Davies, Andrew ; Ando, Kiyoshi ; Klapper, Wolfram ; Opat, Stephen ; Owen, Carolyn ; Phillips, Elizabeth ; Sangha, Randeep ; Schlag, Rudolf ; Seymour, John F ; Townsend, William ; Trněný, Marek ; Wenger, Michael ; Fingerle-Rowson, Günter ; Rufibach, Kaspar ; Moore, Tom ; Herold, Michael ; Hiddemann, Wolfgang

The New England journal of medicine, 2017-10, Vol.377 (14), p.1331-1344 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
6
Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia
Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia

Dimopoulos, Meletios A ; Tedeschi, Alessandra ; Trotman, Judith ; García-Sanz, Ramón ; Macdonald, David ; Leblond, Veronique ; Mahe, Beatrice ; Herbaux, Charles ; Tam, Constantine ; Orsucci, Lorella ; Palomba, M. Lia ; Matous, Jeffrey V ; Shustik, Chaim ; Kastritis, Efstathios ; Treon, Steven P ; Li, Jianling ; Salman, Zeena ; Graef, Thorsten ; Buske, Christian

The New England journal of medicine, 2018-06, Vol.378 (25), p.2399-2410 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
7
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report

Tout, Mira ; Casasnovas, Olivier ; Meignan, Michel ; Lamy, Thierry ; Morschhauser, Franck ; Salles, Gilles ; Gyan, Emmanuel ; Haioun, Corinne ; Mercier, Mélanie ; Feugier, Pierre ; Boussetta, Sami ; Paintaud, Gilles ; Ternant, David ; Cartron, Guillaume

Blood, 2017-05, Vol.129 (19), p.2616-2623 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
8
Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 Years
Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 Years
Material Type:
Artigo 		Adicionar ao Meu Espaço

Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 Years

van Vollenhoven, Ronald F ; Fleischmann, Roy M ; Furst, Daniel E ; Lacey, Stuart ; Lehane, Patricia B

Journal of rheumatology, 2015-10, Vol.42 (10), p.1761-1766 [Periódico revisado por pares]

Canada

Texto completo disponível

Citações Citado por
9
Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed/refractory non–germinal center B-cell–like DLBCL
Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed/refractory non–germinal center B-cell–like DLBCL
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed/refractory non–germinal center B-cell–like DLBCL

Goy, Andre ; Ramchandren, Radhakrishnan ; Ghosh, Nilanjan ; Munoz, Javier ; Morgan, David S. ; Dang, Nam H. ; Knapp, Mark ; Delioukina, Maria ; Kingsley, Edwin ; Ping, Jerry ; Beaupre, Darrin M. ; Neuenburg, Jutta K. ; Ruan, Jia

Blood, 2019-09, Vol.134 (13), p.1024-1036 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
10
AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma
AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma

Leonard, John P ; Trneny, Marek ; Izutsu, Koji ; Fowler, Nathan H ; Hong, Xiaonan ; Zhu, Jun ; Zhang, Huilai ; Offner, Fritz ; Scheliga, Adriana ; Nowakowski, Grzegorz S ; Pinto, Antonio ; Re, Francesca ; Fogliatto, Laura Maria ; Scheinberg, Phillip ; Flinn, Ian W ; Moreira, Claudia ; Cabeçadas, José ; Liu, David ; Kalambakas, Stacey ; Fustier, Pierre ; Wu, Chengqing ; Gribben, John G

Journal of clinical oncology, 2019-05, Vol.37 (14), p.1188-1199 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (504)
  2. Revistas revisadas por pares (478)

Data de Publicação 

De até
Refinar
  1. Antes de2002  (21)
  2. 2002Até2006  (94)
  3. 2007Até2011  (184)
  4. 2012Até2017  (161)
  5. Após 2017  (72)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (530)
  2. Alemão  (1)
  3. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.